You have no items in your shopping cart.
All Products
Biotinylated Human IL-17C (C-6His-Avi) [orb2993679]Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 22.4 KDa. Observed: 24-26 KDa, reducing conditions
100 μg, 20 μg- Biotinylated Human MAdCAM-1 (C-Avi-6His) [orb2993680]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.8 KDa. Observed: 55-80 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human CD147 (C-Avi-6His) [orb2993681]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 30-45 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human TRAIL R2 (C-Avi-6His) [orb2993682]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.1 KDa. Observed: 18-25 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human IGFBP-5 (C-6His-Avi) [orb2993683]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 31.4 KDa. Observed: 32-45 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human NTNG1 (C-Avi-6His) [orb2993684]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.1 KDa. Observed: 55-65 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human PVRIG (C-Fc-Avi) [orb2993685]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.4 KDa. Observed: 50-60 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human IL-17RA (C-6His-Avi) [orb2993686]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.3 KDa. Observed: 50-80 KDa, reducing conditions
100 μg, 20 μg - Recombinant Human CD45R0 (C-6His) [orb2993687]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.2 KDa. Observed: 80-120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 50.9 KDa. Observed: 55-60 KDa, reducing conditions
100 μg, 20 μg